Drug Search Results
More Filters [+]

BAY-987516

Alternative Names: bay-987516, bay987516, bay 987516
Latest Update: 2018-12-13
Latest Update Note: Clinical Trial Update

Product Description

Sunscreening Agent (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02803034?term=NCT02803034&rank=1)

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: N/A

Route of Administration: Topical,Transdermal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Elanco Animal Health
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for BAY-987516

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

SPF Assay

N/A

Completed

Sunburn

2017-01-13

NCT02995122

N/A

Completed

Sunburn

2017-01-06

SPF Assay 201/2016

N/A

Completed

Sunburn

2016-11-03

SPF Assay 203/2016

N/A

Completed

Sunburn

2016-10-19

Recent News Events

Date

Type

Title